Skip to main content
. 2020 Oct 14;13:10409–10416. doi: 10.2147/OTT.S251231

Figure 3.

Figure 3

Overall survival and progression free survival estimates. (A) OS of patients stratified by NRAD1 expression levels (P = 0.0263); (B) PFS of patients stratified by NRAD1 expression levels (P = 0.0174); (C) OS of patients stratified by expression levels (P = 0.0285); (D) PFS of patients stratified by LINC00152 expression levels (P = 0.0041).